This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institute of Zoology, Slovak Academy of Sciences, National University of Singapore. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: Janaki Krishnamoorthy Iyer: Innovator in Thrombin Inhibition
Introduction
Janaki Krishnamoorthy Iyer is a notable inventor based in Singapore, recognized for her contributions to the field of biochemistry. She has developed innovative solutions that address critical medical challenges, particularly in the area of thrombin inhibition. Her work has significant implications for diagnostics and treatment methodologies.
Latest Patents
Janaki holds a patent for her invention related to thrombin inhibitors. The patent describes isolated peptides, variants, and fragments that can bind with high specificity to thrombin, effectively inhibiting its activity. This invention also outlines various applications of these peptides, including their use in diagnostic methods, treatment protocols, and the coating of medical devices. Janaki's patent is a testament to her innovative approach in the medical field, with 1 patent to her name.
Career Highlights
Throughout her career, Janaki has worked with prestigious institutions, including the National University of Singapore and the Institute of Zoology at the Slovak Academy of Sciences. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to significant research advancements.
Collaborations
Janaki has collaborated with esteemed colleagues such as Cho Yeow Koh and R Manjunatha Kini. These partnerships have enriched her research and expanded the impact of her work in thrombin inhibition.
Conclusion
Janaki Krishnamoorthy Iyer's innovative contributions to thrombin inhibition highlight her role as a leading inventor in the medical field. Her work not only advances scientific understanding but also paves the way for improved diagnostic and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile